Involvement of nitric oxide and other molecules with redox potential in primary open angle glaucoma;Implicaciones del óxido nítrico y otras moléculas con potencial redox en el glaucoma primario de ángulo abierto

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 83, Issue 6, 2008, Pages 365-372

  Zanon Moreno V ^a,b   Pons, S ^a   Gallego Pinazo, R ^a,c   Garcia Medina J ^a,d   Vinuesa, I ^a,e   Vila Bou, V ^a,f   Pinazo Durán, María Dolores ^a,f  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HOSPITAL LA INMACULADA   (Spain)

^e HOSPITAL PUNTA DE EUROPA   (Spain)

^f Unidad de Investigación Programas   (Spain)

Author keywords

Antioxidants; Glaucoma; Nitric oxide; Oxidative stress; Reactive oxygen species

Indexed keywords

NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CHEMISTRY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; REACTIVE OXYGEN SPECIES;

EID: 46749111975     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Macknight AD, McLaughlin CW, Peart D, Purves RD, Carre DA, Civan MM. Formation of the aqueous humor. Clin Exp Pharmacol Physiol 2000; 27: 100-106.
2. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389-393.
3. Fuchsjager-Mayrl G, Wally B, Georgopoulos M, Rainer G, Kircher K, Buehl W, et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 2004; 45: 834-839.
4. Nicoara S. Modern concepts in the pathogenesis and treatment of glaucoma. Oftalmologia 2000; 51: 9-13.
5. Lancaster JR Jr, Hibbs JB Jr. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages Proc Natl Acad Sci U S A. 1990; 87: 1223-1227.
6. Khatsenko OG, Gross SS, Rifkind AB, Vane JR. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci USA 1993; 90: 11147-11151.
7. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
8. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
9. Rapoport RM, Draznin MB, Murad F. Endothelium dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 1983; 306: 174-176.
10. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987; 84: 9265-9269.
11. Gerkowicz M, Kosior-Jarecka E, Koziol-Montewka M. Role of nitric oxide in ophthalmic diseases. Klin Oczna 2005; 107: 533-536.
12. Kim JC, Park GS, Kim JK, Kim YM. The role of nitric oxide in ocular surface cells. J Korean Med Sci 2002; 17: 389-394.
13. Chang CJ, Chiang CH, Chow JC, Lu DW. Aqueous humor nitric oxide levels differ in patients with different types of glaucoma. J Ocul Pharmacol Ther 2000; 16: 399-406.
14. Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 1999; 18: 7719-7730.
15. Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol Rev 2000; 80: 315-360.
16. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defense against oxidative stress. Free Radic Res 1999; 31: 273-300.
17. Ottonello S, Foroni C, Carta A, Petrucco S, Maraini G. Oxidative stress and age-related cataract. Ophthalmologica 2000; 214: 78-85.
18. Ethen CM, Reilly C, Feng X, Olsen TW, Ferrington DA. Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal. Invest Ophthalmol Vis Sci 2007; 48: 3469-3479.
19. Verdejo C, Marco P, Renau-Piqueras J, Pinazo-Duran MD. Lipid peroxidation in proliferative vitreoretinopathies. Eye 1999; 13: 183-188.
20. Kawano K, Masuda H, Yano M, Kihara K, Sugimoto A, Azuma H. Altered nitric oxide synthase, arginase and ornithine decarboxylase activities, and polyamine synthesis in response to ischemia of the rabbit detrusor. J Urol 2006; 176: 387-393.
21. Giustarini D, Rossi R, Milzani A, Dalle-Donne I. Nitrite and nitrate measurement by griess reagent in human plasma: evaluation of interferences and standardization. Methods Enzymol 2008; 440: 361-380.
22. Pyles LA, Fortney JE, Kudlak JJ, Gustafson RA, Einzig S. Plasma antioxidant depletion after cardipulmonary bypass in operations for congenital heart disease. J Thorac Cardiovasc Surg 1995; 110: 165-171.
23. Yasar M, Yildiz S, Mas R, Dundar K, Yildirim A, Korkmaz A, et al. The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiol Res 2003; 52: 111-116.
24. Aguirre F, Martin I, Grinspon D, Ruiz M, Hager A, De Paoli T, et al. Farach HA, Poole Jr CP. Oxidative damage, plasma antioxidant capacity, and glucemic control in elderly NIDDM patients. Free Radic Biol Med 1998; 24: 580-585.
25. Anton A, Andrada MT, Mujica V, Calle MA, Portela J, Mayo A. Prevalence of primary open-angle glaucoma in a Spanish population: the Segovia study. J Glaucoma 2004; 13: 371-376.
26. Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy S. Oxidative stress markers in aqueous humour of glaucoma patients. Am J Ophthalmol 2004; 137: 62-69.